Literature DB >> 31567304

The Effect of Progressive Relaxation Exercises on Pain, Fatigue, and Quality of Life in Dialysis Patients.

Emine Kaplan Serin1, Nimet Ovayolu, Özlem Ovayolu.   

Abstract

Patients receiving hemodialysis treatment may experience several symptoms at the same time, such as fatigue and pain. Progressive relaxation exercises (PRE) have been reported to have positive effect on the control of these symptoms. In this study, a randomized, controlled, and experimental study was conducted to examine the effect of PRE on pain, fatigue, and quality of life in hemodialysis patients; the study was carried out with 48 intervention and 48 control patients receiving treatment in the hemodialysis units of 2 hospitals. Data were collected by a questionnaire prepared by the researcher, which included questions about sociodemographic variables and the disease; Piper Fatigue Scale; Visual Analog Scale that measures pain severity; and SF-36 Quality of Life Scale. The results of study revealed that mean total fatigue score and mean pain score decreased in the intervention group after the application of PRE; whereas no change was observed in the control group (P < .05). It was also found that quality of life physical component mean score and mental component mean score increased in the intervention group after the application of PRE (P < .05).

Entities:  

Mesh:

Year:  2020        PMID: 31567304     DOI: 10.1097/HNP.0000000000000347

Source DB:  PubMed          Journal:  Holist Nurs Pract        ISSN: 0887-9311            Impact factor:   1.000


  2 in total

1.  The impact of pain on the quality of life of patients with end-stage renal disease undergoing hemodialysis: a multicenter cross-sectional study from Palestine.

Authors:  Aseel F Samoudi; Maha K Marzouq; Ahmad M Samara; Sa'ed H Zyoud; Samah W Al-Jabi
Journal:  Health Qual Life Outcomes       Date:  2021-02-02       Impact factor: 3.186

2.  Auricular Point Acupressure Combined with Compound Lidocaine Cream to Manage Arteriovenous Fistula Puncture Pain: A Multicenter Randomized Controlled Trial.

Authors:  Xiaohui Liu; Wei Wei; Yaqi Wu; Xiao Jiang; Xueqin Liu; Ying Zhang; Chao Hsing Yeh; Yuejuan Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-28       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.